NYSE · Medical - Care Facilities
EHC (EHC) Stock
$116.68
+2.45%
NYSE: EHC
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
EHC: Lowering target price to $120.00
Argus Research · Jul 15, 2026
Encompass Health announces date of 2026 second quarter earnings call
PR Newswire · Jul 9, 2026
Encompass Health (EHC) Stock May Be A Bargain Following Growing Investor Interest
Simply Wall St. · Jul 9, 2026
Encompass Health (EHC) Could Be 12% Overvalued Following Branford Facility Progress
Simply Wall St. · Jul 8, 2026
1 Cash-Producing Stock Worth Your Attention and 2 We Question
StockStory · Jul 8, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held1.07%
Institutions Held101.63%
Institutions Float Held102.73%
Peer Comparison
About EHC
EHC is led by CEO Mark J. Tarr, employs 42,300 people, headquartered in Birmingham, US, publicly traded since 1986.
EHC stock trades at $116.68 with a market capitalization of $11.57B. The stock is valued at a price-to-earnings (P/E) ratio of 18.97, price-to-book of 4.28, price-to-sales of 1.71. Over the past 52 weeks the stock has ranged between $92.77 and $127.99, and currently trades 8.8% below its 52-week high. It pays a dividend yielding 0.71%.
On profitability, EHC generates a return on equity (ROE) of 23.22% — well above the market average, a sign of a high-quality business, return on capital employed of 32.14%, an operating margin of 17.74%, a net profit margin of 10.04%.